208 related articles for article (PubMed ID: 31343780)
1. Griseofulvin vs terbinafine for paediatric tinea capitis: When and for how long.
Bar J; Samuelov L; Sprecher E; Mashiah J
Mycoses; 2019 Oct; 62(10):949-953. PubMed ID: 31343780
[TBL] [Abstract][Full Text] [Related]
2. Tinea capitis outbreak among paediatric refugee population, an evolving healthcare challenge.
Mashiah J; Kutz A; Ben Ami R; Savion M; Goldberg I; Gan Or T; Zidan O; Sprecher E; Harel A
Mycoses; 2016 Sep; 59(9):553-7. PubMed ID: 27061446
[TBL] [Abstract][Full Text] [Related]
3. Laboratory monitoring during antifungal treatment of paediatric tinea capitis.
Aleohin N; Bar J; Bar-Ilan E; Samuelov L; Sprecher E; Mashiah J
Mycoses; 2021 Feb; 64(2):157-161. PubMed ID: 33064847
[TBL] [Abstract][Full Text] [Related]
4. Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trials.
Elewski BE; Cáceres HW; DeLeon L; El Shimy S; Hunter JA; Korotkiy N; Rachesky IJ; Sanchez-Bal V; Todd G; Wraith L; Cai B; Tavakkol A; Bakshi R; Nyirady J; Friedlander SF
J Am Acad Dermatol; 2008 Jul; 59(1):41-54. PubMed ID: 18378354
[TBL] [Abstract][Full Text] [Related]
5. Systemic antifungal therapy for tinea capitis in children.
Chen X; Jiang X; Yang M; González U; Lin X; Hua X; Xue S; Zhang M; Bennett C
Cochrane Database Syst Rev; 2016 May; 2016(5):CD004685. PubMed ID: 27169520
[TBL] [Abstract][Full Text] [Related]
6. A random comparative study of terbinafine versus griseofulvin in patients with tinea capitis in Western China.
Deng S; Hu H; Abliz P; Wan Z; Wang A; Cheng W; Li R
Mycopathologia; 2011 Nov; 172(5):365-72. PubMed ID: 21701791
[TBL] [Abstract][Full Text] [Related]
7. Improved effectiveness of an increased dose of griseofulvin for treating Tinea capitis among refugee children in Israel: A retrospective cohort study.
Kassem R; Barzilai A; Baum S; Kempfner A; Pavlotsky F
Mycoses; 2023 Dec; 66(12):1064-1070. PubMed ID: 37620517
[TBL] [Abstract][Full Text] [Related]
8. Treatment outcomes for tinea capitis in a skin of color population.
Bhanusali D; Coley M; Silverberg JI; Alexis A; Silverberg NB
J Drugs Dermatol; 2012 Jul; 11(7):852-6. PubMed ID: 22777228
[TBL] [Abstract][Full Text] [Related]
9. Continuous increase of Trichophyton tonsurans as a cause of tinea capitis in the urban area of Paris, France: a 5-year-long study.
Gits-Muselli M; Benderdouche M; Hamane S; Mingui A; Feuilhade de Chauvin M; Guigue N; Picat MQ; Bourrat E; Petit A; Bagot M; Alanio A; Bretagne S
Med Mycol; 2017 Jul; 55(5):476-484. PubMed ID: 27744309
[TBL] [Abstract][Full Text] [Related]
10. Pediatric tinea capitis caused by Trichophyton violaceum and Trichophyton soudanense in Rochester, Minnesota, United States.
Grigoryan KV; Tollefson MM; Olson MA; Newman CC
Int J Dermatol; 2019 Aug; 58(8):912-915. PubMed ID: 30548845
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species.
Lipozencic J; Skerlev M; Orofino-Costa R; Zaitz VC; Horvath A; Chouela E; Romero G; Gourmala N; Paul C;
Br J Dermatol; 2002 May; 146(5):816-23. PubMed ID: 12000378
[TBL] [Abstract][Full Text] [Related]
12. Tinea capitis in children: a systematic review of management.
Gupta AK; Mays RR; Versteeg SG; Piraccini BM; Shear NH; Piguet V; Tosti A; Friedlander SF
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2264-2274. PubMed ID: 29797669
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole.
Gupta AK; Adam P; Dlova N; Lynde CW; Hofstader S; Morar N; Aboobaker J; Summerbell RC
Pediatr Dermatol; 2001; 18(5):433-8. PubMed ID: 11737692
[TBL] [Abstract][Full Text] [Related]
14. Griseofulvin and terbinafine in the treatment of tinea capitis in children.
Rademaker M; Havill S
N Z Med J; 1998 Feb; 111(1060):55-7. PubMed ID: 9539918
[TBL] [Abstract][Full Text] [Related]
15. A randomized comparison of 4 weeks of terbinafine vs. 8 weeks of griseofulvin for the treatment of tinea capitis.
Fuller LC; Smith CH; Cerio R; Marsden RA; Midgley G; Beard AL; Higgins EM; Hay RJ
Br J Dermatol; 2001 Feb; 144(2):321-7. PubMed ID: 11251566
[TBL] [Abstract][Full Text] [Related]
16. Efficacy, safety and tolerability of terbinafine for Tinea capitis in children: Brazilian multicentric study with daily oral tablets for 1,2 and 4 weeks.
Filho ST; Cucé LC; Foss NT; Marques SA; Santamaria JR
J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):141-6. PubMed ID: 9784040
[TBL] [Abstract][Full Text] [Related]
17. Systemic antifungal therapy for tinea capitis in children.
González U; Seaton T; Bergus G; Jacobson J; Martínez-Monzón C
Cochrane Database Syst Rev; 2007 Oct; (4):CD004685. PubMed ID: 17943825
[TBL] [Abstract][Full Text] [Related]
18. New treatments for tinea capitis.
Chan YC; Friedlander SF
Curr Opin Infect Dis; 2004 Apr; 17(2):97-103. PubMed ID: 15021047
[TBL] [Abstract][Full Text] [Related]
19. Tinea capitis outbreak in a paediatric refugee population, Tel Aviv, Israel.
Kopel E; Amitai Z; Sprecher H; Predescu S; Kaliner E; Volovik I
Mycoses; 2012 Mar; 55(2):e36-9. PubMed ID: 21950325
[No Abstract] [Full Text] [Related]
20. Comparison of terbinafine and griseofulvin in the treatment of tinea capitis.
Cáceres-Ríos H; Rueda M; Ballona R; Bustamante B
J Am Acad Dermatol; 2000 Jan; 42(1 Pt 1):80-4. PubMed ID: 10607324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
